A growing movement of biohackers and public figures are exploring nicotine, not as a vice, but as a tool for cognitive enhancement and productivity. Figures like biohacker Dave Asprey, fitness guru Jillian Michaels, and podcast host Joe Rogan have publicly discussed using nicotine, often in the form of tobacco-free pouches, to sharpen focus and improve mental performance.
Asprey, a proponent of the biohacking movement, argues that pharmaceutical-grade nicotine, when separated from tobacco smoke and combustion, acts as a nootropic. He suggests it binds to brain receptors involved in memory and attention, potentially offering neuroprotection. Asprey typically uses low doses, between 2 to 5 milligrams, strategically before deep work or important conversations.
This perspective is mirrored in some tech industry circles, where companies reportedly offer nicotine pouches to employees to boost focus and productivity. The trend has also caught the attention of conservative media personality Tucker Carlson, a co-founder of the brand ALP Nicotine, who has described nicotine as a "life-enhancing, God-given chemical." Even public figures like Robert F. Kennedy Jr. have been observed using nicotine pouches.
The Science Behind the Claims
Research indicates that nicotine can offer short-term cognitive benefits, including increased attention, improved working memory, and enhanced synaptic signaling. However, experts caution that these immediate effects do not necessarily translate to long-term brain health advantages.
"Nicotine can make someone feel sharper, more alert and more focused in the short term. That effect is real," said Dr. Fawad Mian, a neurologist and sleep medicine specialist. "The concern is that the same pathways that create that focus effect also drive dependence. Over time, the brain adapts, and the person may then need nicotine just to feel normal."
Some proponents, including Asprey, point to studies suggesting potential benefits for neurodegenerative diseases like Alzheimer's and Parkinson's. He cites research indicating lower rates of these diseases among regular nicotine users and studies showing nicotine can slow age-related cognitive decline. However, the evidence for such protective effects remains inconclusive.
"Smokers get Parkinson's disease less often. However, when patches were given to patients, they didn’t have the expected effect," Dr. Mian explained. "In patients with early Parkinson’s, there was no clear benefit aside from temporary cognitive improvement."
Dr. Nehal Vadhan, director of Northwell Health’s Feinstein Family Human Neuropsychopharmacology Lab, noted that while associative and mechanistic evidence exists, clinical trials have not consistently demonstrated efficacy, particularly for preventative use in healthy individuals.
Risks and Alternatives
The primary concern among medical experts is the potential for dependence. "While everyone agrees that tobacco consumption is considerably worse, there aren’t long-term studies to demonstrate complete safety of pouches, especially when you consider all the additives," Dr. Vadhan stated.
Asprey acknowledges variations in product quality, advising users to select pharmaceutical-grade nicotine from reputable brands and to research pouch materials to avoid potential contaminants like microplastics. He also emphasized that the science is still developing, particularly regarding long-term effects on mitochondrial health.
Experts like Dr. Mian suggest prioritizing well-established strategies for cognitive health. "If you want to help your memory, focusing on sleep, diet, exercise, controlling your blood pressure and blood sugars, learning new things and staying socially active are much safer alternatives that avoid addiction or potential long-term health consequences," he advised. "Nicotine may act like a short-term cognitive stimulant, but it has not earned the label of a brain-health supplement just yet."